Samsung Biologics Finalizes Rights Offering Price at KRW 1.17 Million per Share

Bitget2026/11/05 07:39

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Samsung Biologics finalized its rights offering price at KRW 1.17 million per common share in a November 5, 2026, correction.
The offering comprises 2,270,000 new common shares, raising KRW 2.66 trillion to acquire securities in another company.
Fair Trade Commission reporting now applies following participation decisions by Samsung C&T on October 28 and Samsung Electronics on October 29.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261105000355), on November 05, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Samsung Biologics Finalizes Rights Offering Price at KRW 1.17 Million per Share

You may also like

Crypto prices